News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,772 Results
Type
Article (62925)
Company Profile (264)
Press Release (634583)
Multimedia
Podcasts (79)
Webinars (13)
Section
Business (186780)
Career Advice (2806)
Deals (34675)
Drug Delivery (109)
Drug Development (83937)
Employer Resources (161)
FDA (16075)
Job Trends (14884)
News (329089)
Policy (31822)
Tag
Academia (2816)
Academic (2)
Accelerated approval (6)
Adcomms (26)
Allergies (93)
Alliances (46940)
ALS (99)
Alzheimer's disease (1498)
Antibody-drug conjugate (ADC) (132)
Approvals (16063)
Artificial intelligence (276)
Autoimmune disease (27)
Automation (15)
Bankruptcy (310)
Best Places to Work (11784)
BIOSECURE Act (20)
Biosimilars (110)
Biotechnology (182)
Bladder cancer (83)
Brain cancer (29)
Breast cancer (291)
Cancer (2345)
Cardiovascular disease (198)
Career advice (2370)
Career pathing (33)
CAR-T (162)
Cell therapy (457)
Cervical cancer (20)
Clinical research (67906)
Collaboration (864)
Compensation (483)
Complete response letters (29)
COVID-19 (2752)
CRISPR (47)
C-suite (259)
Cystic fibrosis (106)
Data (2239)
Decentralized trials (2)
Denatured (28)
Depression (48)
Diabetes (277)
Diagnostics (6535)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (42)
Drug discovery (129)
Drug pricing (113)
Drug shortages (24)
Duchenne muscular dystrophy (97)
Earnings (68385)
Editorial (41)
Employer branding (19)
Employer resources (141)
Events (108639)
Executive appointments (764)
FDA (17374)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (783)
Gene editing (117)
Generative AI (24)
Gene therapy (338)
GLP-1 (761)
Government (4810)
Grass and pollen (6)
Guidances (61)
Healthcare (19504)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (144)
Indications (30)
Infectious disease (2909)
Inflammatory bowel disease (152)
Inflation Reduction Act (9)
Influenza (56)
Intellectual property (101)
Interviews (533)
IPO (16199)
IRA (45)
Job creations (3561)
Job search strategy (1991)
Kidney cancer (11)
Labor market (30)
Layoffs (524)
Leadership (22)
Legal (6974)
Liver cancer (77)
Lung cancer (335)
Lymphoma (153)
Machine learning (7)
Management (56)
Manufacturing (293)
MASH (71)
Medical device (13264)
Medtech (13269)
Mergers & acquisitions (19067)
Metabolic disorders (708)
Multiple sclerosis (87)
NASH (22)
Neurodegenerative disease (110)
Neuropsychiatric disorders (30)
Neuroscience (2081)
NextGen: Class of 2025 (6853)
Non-profit (4795)
Now hiring (16)
Obesity (368)
Opinion (252)
Ovarian cancer (73)
Pain (94)
Pancreatic cancer (84)
Parkinson's disease (161)
Partnered (21)
Patents (240)
Patient recruitment (113)
Peanut (51)
People (60080)
Pharmaceutical (68)
Pharmacy benefit managers (18)
Phase I (21066)
Phase II (29809)
Phase III (22253)
Pipeline (1212)
Policy (149)
Postmarket research (2839)
Preclinical (9255)
Press Release (68)
Prostate cancer (113)
Psychedelics (32)
Radiopharmaceuticals (264)
Rare diseases (425)
Real estate (6112)
Recruiting (65)
Regulatory (22261)
Reports (33)
Research institute (2515)
Resumes & cover letters (426)
Rett syndrome (5)
RNA editing (5)
RSV (46)
Schizophrenia (74)
Series A (138)
Series B (90)
Service/supplier (9)
Sickle cell disease (57)
Special edition (15)
Spinal muscular atrophy (162)
Sponsored (29)
Startups (3525)
State (1)
Stomach cancer (11)
Supply chain (63)
Tariffs (30)
The Weekly (49)
Vaccines (768)
Venture capitalists (39)
Weight loss (246)
Women's health (33)
Worklife (19)
Date
Today (168)
Last 7 days (869)
Last 30 days (2707)
Last 365 days (33321)
2025 (10893)
2024 (35459)
2023 (39823)
2022 (50894)
2021 (55694)
2020 (54438)
2019 (47721)
2018 (36234)
2017 (32889)
2016 (32478)
2015 (37932)
2014 (30928)
2013 (26810)
2012 (28360)
2011 (28538)
2010 (27290)
Location
Africa (939)
Alabama (56)
Alaska (7)
Arizona (179)
Arkansas (13)
Asia (40683)
Australia (7230)
California (6048)
Canada (1961)
China (529)
Colorado (264)
Connecticut (282)
Delaware (147)
Europe (94866)
Florida (910)
Georgia (202)
Idaho (60)
Illinois (564)
India (26)
Indiana (306)
Iowa (9)
Japan (164)
Kansas (99)
Kentucky (24)
Louisiana (12)
Maine (61)
Maryland (896)
Massachusetts (4555)
Michigan (230)
Minnesota (372)
Mississippi (2)
Missouri (89)
Montana (31)
Nebraska (24)
Nevada (63)
New Hampshire (63)
New Jersey (1761)
New Mexico (31)
New York (1739)
North Carolina (1035)
North Dakota (8)
Northern California (2616)
Ohio (206)
Oklahoma (15)
Oregon (37)
Pennsylvania (1336)
Puerto Rico (11)
Rhode Island (32)
South America (1293)
South Carolina (23)
South Dakota (1)
Southern California (2268)
Tennessee (97)
Texas (901)
United States (23077)
Utah (177)
Virginia (152)
Washington D.C. (60)
Washington State (557)
West Virginia (3)
Wisconsin (60)
697,772 Results for "infectious diseases society of america idsa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Selected the EnACT Phase 2 Trial Abstract of MAT2203 as its Outstanding Abstract and IDSA Awardee For IDWeek 2022
Matinas BioPharma Holdings, Inc. today announced that the Infectious Diseases Society of America (IDSA), one of the four sponsoring societies for IDWeek 2022.
October 19, 2022
·
6 min read
Press Releases
SCYNEXIS to Present Preclinical Data on Second Generation IV/Oral Fungerp SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
April 9, 2025
·
5 min read
Press Releases
Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
April 7, 2025
·
5 min read
Press Releases
Vast Granted Qualified Infectious Disease Product Designation from the FDA
March 26, 2025
·
3 min read
Press Releases
Novotech Report Reveals Global Surge in Infectious Disease Trials as Industry Nears 2,000 Studies Since 2020
April 2, 2025
·
3 min read
Press Releases
Biotia Announces Collaboration with Mayo Clinic to Advance Microbial Identification for Infectious Disease Diagnostics
April 3, 2025
·
2 min read
BioCapital
Infectious Diseases Society of America Foundation Announces Applications for Microbial Pathogenesis in Alzheimer’s Research Grant
The Infectious Diseases Society of America Foundation is now accepting applications for the Microbial Pathogenesis in Alzheimer’s Disease Grant.
September 26, 2022
·
2 min read
Press Releases
Mitsubishi Tanabe Pharma America to Share Latest Data on Investigational ND0612 at the 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD)
April 1, 2025
·
4 min read
Press Releases
BD to Present at Bank of America Securities Health Care Conference
May 1, 2025
·
1 min read
Press Releases
RxSight, Inc. to Present at the Bank of America Healthcare Conference
May 1, 2025
·
1 min read
1 of 69,778
Next
